BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3928424)

  • 1. [Gonadotropin stimulation during LH/RH analog-induced inhibition of pituitary function].
    Bettendorf G; Braendle W; Sprotte C
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):431-7. PubMed ID: 3928424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gonadotropin treatment in ovarian insufficiency, stimulation of follicle maturation with human urinary FSH].
    Braendle W; Sprotte C; Bettendorf G
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):438-48. PubMed ID: 3928425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stimulation of ovarian function with gonadotropins following suppression of endogenous gonadotropin secretion by long-term infusion of the LHRH analog buserelin].
    Geisthövel F; Bliefert R; Geyer H; Breckwoldt M; Sandow J
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):240-5. PubMed ID: 3109997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study of the treatment of sterility in hyperandrogenic ovarian insufficiency].
    Westhof G; Braendle W; Sprotte C; Zimmermann R; Bettendorf G
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):449-58. PubMed ID: 3928426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of serum FSH, LH and hCG after i.m. or i.v. administration of hMG during pituitary suppression.
    Duijkers IJ; Hollanders HM; Willemsen WN; de Leeuw R; Vemer HM
    Int J Fertil Menopausal Stud; 1995; 40(2):86-91. PubMed ID: 7599664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of follicle-stimulating hormone and luteinizing hormone after subcutaneous administration of human menopausal gonadotropin during pituitary suppression.
    Duijkers IJ; Magnusson YM; Hollanders HM
    Int J Fertil Menopausal Stud; 1995; 40(6):307-10. PubMed ID: 8748920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
    Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
    Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the GnRH analog buserelin on sex hormone serum level in relation to treatment onset and duration].
    Urbancsek J; Rabe T; Gör U; Schulte B; Grunwald K; Papp Z; Runnebaum B
    Geburtshilfe Frauenheilkd; 1991 Aug; 51(8):617-25. PubMed ID: 1834511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
    Abuzeid MI; Yeoman R; Aksel S
    Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monthly administration of the LH-RH analogue decapeptyl for long-term treatment of ovarian dysfunctions and estrogen-dependent disorders.
    Geisthoevel F; Hils K; Wieacker P; Breckwoldt M; Schultheiss H
    Int J Fertil; 1989; 34(4):262-70. PubMed ID: 2570764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma estrogen monitoring of ovulation induction.
    Wu CH
    Obstet Gynecol; 1975 Sep; 46(3):294-8. PubMed ID: 1172219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
    Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
    Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gonadotropin stimulation and in vitro fertilization following selective hypophyseal suppression by LH/RH analogs].
    Lindner C; Braendle W; Bispink L; Lichtenberg V; Bettendorf G
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):490-4. PubMed ID: 3114041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to improve ovarian response by combined gonadotropin-releasing hormone agonist and gonadotropin therapy.
    Bider D; Kokia E; Lipitz S; Blankstein J; Mashiach S; Serr DM; Ben-Rafael Z
    Gynecol Obstet Invest; 1990; 29(3):192-6. PubMed ID: 2113505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete ovarian unresponsiveness to hMG stimulation after prolonged GnRH analogue administration.
    Ben-Nun I; Jaffe R; Goldberger S; Ghetler Y; Kaneti H; Fejgin M
    Gynecol Endocrinol; 1990 Sep; 4(3):151-5. PubMed ID: 2126660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.